These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Olde Nordkamp LR, Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR. Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262 [Abstract] [Full Text] [Related]
8. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes. Kumar S, Peters S, Thompson T, Morgan N, Maccicoca I, Trainer A, Zentner D, Kalman JM, Winship I, Vohra JK. Heart Rhythm; 2013 Nov; 10(11):1653-60. PubMed ID: 23973953 [Abstract] [Full Text] [Related]
9. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Roses-Noguer F, Jarman JW, Clague JR, Till J. Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999 [Abstract] [Full Text] [Related]
10. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Schinkel AF. Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907 [Abstract] [Full Text] [Related]
17. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death. Yin K, Ding L, Li Y, Hua W. Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837 [Abstract] [Full Text] [Related]